SCHEMBL10000460

SCHEMBL10000460

CCN(C)c1ccc2cc(Br)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CYP2A6 P11509 1/20 0.43
NCEH1 Q6PIU2 2/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 3/20 0.41
IGLV6-57 P01721 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
SLC6A2 P23975 2/20 0.36
TERT O14746 1/20 0.36
BACE1 P56817 1/20 0.36
APP P05067 4/20 0.35
MAPK1 P28482 2/20 0.34
USP2 O75604 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5593736 0.82 TERT (0.55) LMNAL3MBTL1CYP2A6MAPTKDM4E
SCHEMBL3240233 0.80 CYP2A6 (0.47) L3MBTL1CYP2A6IGLV6-57ADRA2AADRA2B
SCHEMBL29543329 0.79 APP (0.50) LMNAL3MBTL1CYP2A6NCEH1MAPT
SCHEMBL645807 0.79 APP (0.50) LMNAL3MBTL1CYP2A6NCEH1MAPT
SCHEMBL1433223 0.79 ADRA2A (0.48) L3MBTL1CYP2A6MAPTKDM4EMEN1
SCHEMBL17268809 0.78 IGLV6-57 (0.47) L3MBTL1MAPTKDM4EALDH1A1IGLV6-57
SCHEMBL4064736 0.76 HTR7 (0.44) LMNAALDH1A1MAPK1GAA
SCHEMBL16682949 0.75 ADRA2A (0.46) L3MBTL1CYP2A6MAPTKDM4EMEN1
SCHEMBL31457375 0.74 APP (0.48) CYP2A6NCEH1MAPTKDM4EMEN1
SCHEMBL10330355 0.71 ADRA2A (0.58) L3MBTL1CYP2A6MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8557811-B2 Dual-color imaging method of sodium/calcium activities using two-photon fluorescent probes and preparation method of two-photon fluorescent probes Ajou University Industry—Academic Cooperation Foundation (KR) 2013-10-15 US disclosed
US-20120035360-A1 DUAL-COLOR IMAGING METHOD OF SODIUM/CALCIUM ACTIVITIES USING TWO-PHOTON FLUORESCENT PROBES AND PREPARATION METHOD OF TWO-PHOTON FLUORESCENT PROBES AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035360-A1 DUAL-COLOR IMAGING METHOD OF SODIUM/CALCIUM ACTIVITIES USING TWO-PHOTON FLUORESCENT PROBES AND PREPARATION METHOD OF TWO-PHOTON FLUORESCENT PROBES CACNB2, CA2, ATP2A2 LMNA 773/4885L3MBTL1 3676/4885CYP2A6 3082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.